- US Stock Movement | Beyond Meat Plunges 21% in Pre-market Trading
- Neurogene publishes corporate presentation highlighting NGN-401 gene therapy program for Rett syndrome
- Metal Energy to issue 550,000 shares at C$0.89 in Centerra, Teck top-up placement
- $19 Billion AI Bet Backfires as Korean Retail Suffers Worst KOSPI Crash Since 2008
- Market News: The total assets under management in the German fund industry have surpassed €5 trillion for the first time.
- Nvidia’s $500B AI Infrastructure Push Could Deepen Divide With Decentralized Networks
- Natura publishes Q2 2026 results presentation
- Mermaid Maritime appoints Ms Chayanan Sakornsakolpat as company secretary
- Organigram Q3 FY2026 net revenue rises 49% to CAD 105.78 million, driven by Sanity Group contribution, company says
- Mermaid Maritime 1H FY26 net loss narrows 53.2% to USD 7.23 million
- Aura Biosciences releases corporate deck outlining bel-sar strategy in ocular oncology
- Breaking: National Bank of Canada Reveals Holdings In XRP ETF, Bitcoin ETFs
- Littelfuse director Kelsey files initial beneficial ownership statement
- Natural gas: European prices surge as LNG flows stall – ING
- Mermaid Maritime enters 50:50 JV with DS Global to reactivate Mermaid Commander vessel
- Farewell to "K-shaped divergence"? PNC report: The gap in consumption between high- and low-income households in the U.S. will basically disappear by 2026, with the labor market as the key support
- COGENT BIOSCIENCES, INC. <COGT.O>: GUGGENHEIM RAISES TARGET PRICE TO $52 FROM $45
- Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases
- Ryman Hospitality plans USD 700 million senior notes offering due 2035
- Gelum Resources grants 1,100,000 stock options at $0.90 per share
- Metals Creek hits 7.25 g/t gold over 7.45 m at Ogden project in Ontario
- Incannex wins approval of overseas findings, secures A$5.1 million R&D tax refund
- CDN Maverick holds 3.3 million Noram Lithium shares, 1.65 million warrants in portfolio update
- NovaRed Mining reports trench samples up to 1.67% copper at Wilmac project in British Columbia
- Bicara Q2 FY26 net loss widens 102.4% to $55.44 million
- Turnium Technology Group adopts TTGI as primary corporate brand identity
- The SEC will discuss a regulatory framework for crypto token issuance.
- Littelfuse appoints Plexus CEO Todd Kelsey to board, names him to compensation panel
- Ambiq Q2 FY26 GAAP net loss narrows to $7.12 million; net sales rise 89.7% to $33.9 million year over year
- Eltek updates financial calendar with Q2 2026 earnings release and conference call schedule
- EVgo opens new flagship fast-charging site near GM technical center in Detroit metro area
- Stardust Power appoints Ray Rivers to board, names him to audit and compensation committees
- Sagimet net loss widens to $14 million in Q2 FY26; R&D expense climbs to $11.54 million
- From 1.5GW Reservation to $20 Billion Valuation Ambition: Singapore Data Center Operator DayOne Rushes for US IPO
- Zura Bio Q2 FY26 net loss widens to $26.3 million; R&D expense more than doubled to $20.7 million
- From 1.5GW Bookings to a $20 Billion Ambition: Singapore Data Center Operator DayOne Races Toward US IPO
- Egypt: MELEIHA Natural Gas Plant Project in the Western Desert to Begin Operations Next Month with a Daily Capacity of 100 Million Cubic Feet
- BRIEF-Intensity Therapeutics Q2 Operating Income USD -3.084 Million
- BRIEF-Neurogene Q2 Operating Expenses USD 36.67 Million
- Neurogene 2Q Research & Development Expenses $25.5M >NGNE
- Bicara Names Jenn Larson CFO
- Intensity Therapeutics 2Q Loss/Shr $1.11 >INTS
- Intensity Therapeutics 2Q Loss $3.01M >INTS
- Neurogene 2Q Loss/Shr $1.53 >NGNE
- Veradermics Q2 FY26 net loss widens to $23.5 million; R&D expense rises to $18.61 million
- Neurogene Q2 FY26 net loss widens to USD 34.49 million
- Intermap appoints former OMERS CEO J. Michael Rolland to board
- Deep Sea Minerals welcomes Trump comment on authorizing deep-sea mining at US roundtable
- Bitget Protection Fund valuation climbs to $351M as Bitcoin rallies in July
- Trump Media & Technology Group stock wobbles after $238M quarterly loss
- Chainlink crypto nears 9.48 resistance as RSI hits overbought 77.61
- Algo Grande Copper logs expanded copper mineralization in Adelita Phase II Hole 2
- Bicara Therapeutics 2Q Loss/Shr 82c >BCAX
- Zura Bio Expects Existing Cash and Cash Equivalents Sufficient to Support Planned Ops Through at Least End of 2028 >ZURA
- Sagimet Biosciences 2Q Loss/Shr 26c >SGMT
- Ambiq Micro 2Q Sales $33.9M >AMBQ
- Zura Bio 2Q Loss $26.3M >ZURA
- Ambiq Micro 2Q Loss/Shr 32c >AMBQ
- HIMS & HERS HEALTH, INC. <HIMS.N>: TD COWEN RAISES TARGET PRICE TO $30 FROM $25
- ATS held virtual annual and special shareholders meeting
- MERCK & CO INC <MRK.N>: ARGUS RESEARCH RAISES TARGET PRICE TO $145 FROM $130
- CENTENE CORP <CNC.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- Stellar price risks a deeper correction toward $0.142
- Harvard Apparatus adjusted EBITDA rises 11% year over year to $1.7 million; revenue increases 11% to $22.7 million in 2Q26
- Delfi 1H FY26 PATMI rises 5.4% to US$12.9 million; net sales climb 2.7% to US$266.6 million
- Cadeler buys offshore foundation installer Menck for EUR 501 million
- BOEING <BA.N>: ARGUS RESEARCH RAISES TO BUY FROM HOLD
- NEWMONT <NEM.N>: RAYMOND JAMES RAISES TARGET PRICE TO $131 FROM $128
- RAPID7, INC. <RPD.O>: RAYMOND JAMES RAISES TARGET PRICE TO $15 FROM $8
- SEC Tees Up New Crypto Rulebook As XRP Wobbles
- Upstream Bio posts corporate presentation highlighting verekitug Phase 3 plans in severe asthma, CRSwNP
- Havila Kystruten targets 10% average cabin revenue growth in 2026
- APPLIED OPTOELECTRONICS, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $178 FROM $151
- BARRICK MINING <B.N>: RAYMOND JAMES CUTS TARGET PRICE TO $56 FROM $58
- Babcock & Wilcox Shares Gain After Signing of Data-Center Power Agreement
- SIONNA THERAPEUTICS, INC. <SION.O>: WEDBUSH CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $5 FROM $53
- Fleury board okays disclosure of Q2 2026 financial results
- Japanese Yen: Wider range with intervention support against US Dollar – HSBC
- Top 3 Price Prediction: Bitcoin (BTC), Ethereum (ETH), XRP (XRP)
- Legacy Gold Mines hits 1.14 g/t gold over 13.5 m from surface at Baner project, Idaho
- GOLD X2 MINING INC : STIFEL INITIATES COVERAGE WITH BUY RATING; PRICE TARGET C$15
- Intensity Therapeutics Q2 FY26 net loss widens 18.53% to $3.01 million
- Freja eID Group to host investor webinar after Q2 report
- 908 Devices forecasts 2026 revenue from continuing operations of $68 million to $70 million
- VERA THERAPEUTICS, INC. <VERA.O>: WEDBUSH CUTS TARGET PRICE TO $34 FROM $43
- Fennec Pharmaceuticals 2Q EPS 5c >FRX.T
- Fennec Pharmaceuticals 2Q Rev $17.9M >FRX.T
- CalciMedica 2Q Research and Development Expenses $2.1M >CALC
- Terrestrial Energy 2Q Loss/Shr 9c >IMSR
- CalciMedica 2Q Loss/Shr 45c >CALC
- 908 Devices Narrows 2026 View To Rev $68.0M-$70.0M >MASS
- 908 Devices 2Q Loss/Shr 32c >MASS
- Aura Biosciences 2Q Loss/Shr 48c >AURA
- CVRx: Paul Verrastro to Assume Role of Interim Head of Sales, Effective Immediately >CVRX
- C4 Therapeutics 2Q Loss/Shr 18c >CCCC
- Xtant Medical Holdings 2Q Rev $23M >XTNT
- Dow Jones Top Company Headlines at 7 AM ET: Anthropic Tries to Shore Up Investor Confidence Ahead of Blockbuster IPO | Smithfield ...
- Prelude Therapeutics 2Q Rev $5.7M >PRLD
- Kardigan 2Q Loss/Shr $4.61 >KARD
- Xtant Medical Holdings 2Q Loss $9.41M >XTNT
